 I'm Jerry Willis, and this is the Fox Business Report. Eli Lilly will buy biopharmaceutical company Morphic Holding for $3.2 billion. The sale is expected to be completed in the third quarter. Morphic is leading the way in developing treatment for serious chronic diseases, including ulcerative colitis and Crohn's disease. The world's biggest aerospace company is now a felon.